Lumpy, thanks for the quick reply. I have the same impression.
To add:
There is no adequat treatment for GVHD except from Prednisone. Orbec has no side effects. The drug missed the primary endpoint short term but fullfilled 80 and 200 days overall survival rate. Please comment. For the FDA there is not a big risk to approve the drug. Your comparison with dndn is good. I think Dor is in a better situation because Dndn drug is taylormade for each patient. Orbec is a drug that fits for every patient. Is this a opportunity that is flying under the radar? Why is it sticking around at 27 cents? The price is absolutely ridiculous.